A Computational Network Biology Approach to Uncover Novel Genes Related to Alzheimer’s Disease

Author(s):  
Andreas Zanzoni
2019 ◽  
Vol 137 (4) ◽  
pp. 557-569 ◽  
Author(s):  
Stephen A. Semick ◽  
Rahul A. Bharadwaj ◽  
Leonardo Collado-Torres ◽  
Ran Tao ◽  
Joo Heon Shin ◽  
...  

2020 ◽  
Vol 75 (2) ◽  
pp. 531-545 ◽  
Author(s):  
Bo-Hyun Kim ◽  
Yong-Ho Choi ◽  
Jin-Ju Yang ◽  
SangYun Kim ◽  
Kwangsik Nho ◽  
...  

NeuroImage ◽  
2010 ◽  
Vol 51 (2) ◽  
pp. 542-554 ◽  
Author(s):  
Jason L. Stein ◽  
Xue Hua ◽  
Jonathan H. Morra ◽  
Suh Lee ◽  
Derrek P. Hibar ◽  
...  

2018 ◽  
Author(s):  
Stephen A. Semick ◽  
Rahul A. Bharadwaj ◽  
Leonardo Collado-Torres ◽  
Ran Tao ◽  
Joo Heon Shin ◽  
...  

AbstractBackgroundLate-onset Alzheimer’s disease (AD) is a complex age-related neurodegenerative disorder that likely involves epigenetic factors. To better understand the epigenetic state associated with AD represented as variation in DNA methylation (DNAm), we surveyed 420,852 DNAm sites from neurotypical controls (N=49) and late-onset AD patients (N=24) across four brain regions (hippocampus, entorhinal cortex, dorsolateral prefrontal cortex and cerebellum).ResultsWe identified 858 sites with robust differential methylation, collectively annotated to 772 possible genes (FDR<5%, within 10kb). These sites were overrepresented in AD genetic risk loci (p=0.00655), and nearby genes were enriched for processes related to cell-adhesion, immunity, and calcium homeostasis (FDR<5%). We analyzed corresponding RNA-seq data to prioritize 130 genes within 10kb of the differentially methylated sites, which were differentially expressed and had expression levels associated with nearby DNAm levels (p<0.05). This validated gene set includes previously reported (e.g. ANK1, DUSP22) and novel genes involved in Alzheimer’s disease, such as ANKRD30B.ConclusionsThese results highlight DNAm changes in Alzheimer’s disease that have gene expression correlates, implicating DNAm as an epigenetic mechanism underlying pathological molecular changes associated with AD. Furthermore, our framework illustrates the value of integrating epigenetic and transcriptomic data for understanding complex disease.


PLoS Genetics ◽  
2021 ◽  
Vol 17 (2) ◽  
pp. e1009363
Author(s):  
Nana Liu ◽  
Jiayuan Xu ◽  
Huaigui Liu ◽  
Shijie Zhang ◽  
Miaoxin Li ◽  
...  

Genome-wide association studies (GWASs) have identified multiple susceptibility loci for Alzheimer’s disease (AD), which is characterized by early and progressive damage to the hippocampus. However, the association of hippocampal gene expression with AD and the underlying neurobiological pathways remain largely unknown. Based on the genomic and transcriptomic data of 111 hippocampal samples and the summary data of two large-scale meta-analyses of GWASs, a transcriptome-wide association study (TWAS) was performed to identify genes with significant associations between hippocampal expression and AD. We identified 54 significantly associated genes using an AD-GWAS meta-analysis of 455,258 individuals; 36 of the genes were confirmed in another AD-GWAS meta-analysis of 63,926 individuals. Fine-mapping models further prioritized 24 AD-related genes whose effects on AD were mediated by hippocampal expression, including APOE and two novel genes (PTPN9 and PCDHA4). These genes are functionally related to amyloid-beta formation, phosphorylation/dephosphorylation, neuronal apoptosis, neurogenesis and telomerase-related processes. By integrating the predicted hippocampal expression and neuroimaging data, we found that the hippocampal expression of QPCTL and ERCC2 showed significant difference between AD patients and cognitively normal elderly individuals as well as correlated with hippocampal volume. Mediation analysis further demonstrated that hippocampal volume mediated the effect of hippocampal gene expression (QPCTL and ERCC2) on AD. This study identifies two novel genes associated with AD by integrating hippocampal gene expression and genome-wide association data and reveals candidate hippocampus-mediated neurobiological pathways from gene expression to AD.


2021 ◽  
Vol 17 (S5) ◽  
Author(s):  
Pradeep Varathan ◽  
Priyanka Gorijala ◽  
Tanner Y. Jacobson ◽  
Kwangsik Nho ◽  
Shannon L. Risacher ◽  
...  

2020 ◽  
Vol 16 (8) ◽  
pp. 1134-1145
Author(s):  
Richard Sherva ◽  
Alden Gross ◽  
Shubhabrata Mukherjee ◽  
Ryan Koesterer ◽  
Philippe Amouyel ◽  
...  

PLoS ONE ◽  
2019 ◽  
Vol 14 (7) ◽  
pp. e0218111 ◽  
Author(s):  
Emily Baker ◽  
Rebecca Sims ◽  
Ganna Leonenko ◽  
Aura Frizzati ◽  
Janet C. Harwood ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document